Diligence memo · auto-generated · as of July 2, 2026
KayoThera, Inc.
KayoThera, Inc. looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
KayoThera, Inc. operates in Other, based in Seattle.
Sector still resolves to a broad 'Other' bucket, so operating comparables below are weaker than for a tightly-classified peer.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
KayoThera, Inc. has raised $11M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $10M on 2022-03-11.
Most recent recorded round closed around 2022-03-11.
Valuation (modeled)modeled
Provath models KayoThera, Inc. at approximately $95M (range $14M–$351M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.45× the median modeled value of Series A Other companies in 2022–2024 (1135 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 11 months.
Last raise 4.3 yr ago; this sector typically re-raises about every 11 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 1.3× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 79% of Other peers (25015 compared).
Modeled value ranks above 82% of those peers.
Closest niche peers: Ness Well, Inc., Quantori, Inc., Qquv Investments 5, Llc, Applause Network TV, Inc., Trustworthy Co.
Peoplefiled
9 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
Broad sector classification weakens peer comparison.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.